Camson Bio Technologies logo

538858 - Camson Bio Technologies Share Price

₹3.31 0.0  0.0%

Last Trade - 11/05/20

Sector
Basic Materials
Size
Micro Cap
Market Cap £1.07m
Enterprise Value £6.45m
Revenue £n/a
Position in Universe 2622nd / 2984
Bullish
Bearish
Unlock 538858 Revenue
Momentum
Relative Strength (%)
1m -12.1%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Mar 2013 2014 2015 2016 2017 2018 2019E 2020E CAGR / Avg
1,360 1,909 2,030 621.2 153.9 193.1 -32.3%
-14.8 -42.2 -88.1
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the fiscal year ended 31 March 2018, Camson Bio Technologies Ltd revenues increased 25% to RS193.1M. Net loss applicable to common stockholders decreased 52% to RS143.2M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Lower net loss reflects Other Expenses decrease of 59% to RS65.3M (expense), Financial costs - Balancing value decrease of 70% to RS7.3M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

538858 Revenue Unlock 538858 Revenue

Net Income

538858 Net Income Unlock 538858 Revenue

Normalised EPS

538858 Normalised EPS Unlock 538858 Revenue

PE Ratio Range

538858 PE Ratio Range Unlock 538858 Revenue

Dividend Yield Range

538858 Dividend Yield Range Unlock 538858 Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
538858 EPS Forecasts Unlock 538858 Revenue
Profile Summary

Camson Bio Technologies Limited is an agricultural biotechnology company. The Company's segments include Seeds & Vegetables, and Agri Biotech Products. It produces farming products, which uses secondary metabolites (biological origin) of microbes to kill/inhibit pathogens. It is focused on manufacturing natural pest management products for the agricultural markets. Its products include biocides, natural fertilizer, bio fertilizer and stimulants, and hybrid seed varieties. Its biocides include bio-insecticide, such as CAL-MB, CALTERM, CALNOVA, CALHOPP and CALPASTE, and bio-fungicides, such as CALPHOMIL, CALDERMA, CALBASE and CALTOP. Its natural fertilizers include CALPUSHTI, CALTRUPTI, CALVRIDHI and CALSRISTI. Its bio fertilizer and stimulants include CALSHRI, CALSTIM, CALTIKA, CALIPSO, CALRRHIZA, CALOBIUM, CALMONAS and CALPHOROUS. Its hybrid seed varieties include hybrid vegetables seeds, such as tomato, brinjal and chilli, and hybrid fruit seeds, such as watermelon and musk melon.

Directors
Last Annual March 31st, 2018
Last Interim March 31st, 2015
Incorporated November 19, 1993
Public Since January 29, 2008
No. of Shareholders: n/a
No. of Employees: 200
Sector Basic Materials
Industry Chemicals
Index
Exchange Bombay Stock Exchange
Shares in Issue 29,999,840
Free Float (0.0%)
Eligible for
ISAs
SIPPs
538858 Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for 538858
Upcoming Events for 538858
Frequently Asked Questions for Camson Bio Technologies
What is the Camson Bio Technologies share price?

As of 11/05/20, shares in Camson Bio Technologies are trading at ₹3.31, giving the company a market capitalisation of £1.07m. This share price information is delayed by 15 minutes.

How has the Camson Bio Technologies share price performed this year?

Shares in Camson Bio Technologies are currently trading at ₹3.31 and the price has moved by -55.87% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Camson Bio Technologies price has moved by -52.46% over the past year.

What are the analyst and broker recommendations for Camson Bio Technologies?

Of the analysts with advisory recommendations for Camson Bio Technologies, there are there are currently "buy" , "hold" and "sell" recommendations. The overall consensus recommendation for Camson Bio Technologies is Not available. You can view the full broker recommendation list by unlocking its StockReport.

When will Camson Bio Technologies next release its financial results?

Camson Bio Technologies is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2016-03-31
What is the Camson Bio Technologies dividend yield?

Camson Bio Technologies does not currently pay a dividend.

Does Camson Bio Technologies pay a dividend?

Camson Bio Technologies does not currently pay a dividend.

When does Camson Bio Technologies next pay dividends?

Camson Bio Technologies does not currently pay a dividend.

How do I buy Camson Bio Technologies shares?

To buy shares in Camson Bio Technologies you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Camson Bio Technologies?

Shares in Camson Bio Technologies are currently trading at ₹3.31, giving the company a market capitalisation of £1.07m.

Where are Camson Bio Technologies shares listed? Where are Camson Bio Technologies shares listed?

Here are the trading details for Camson Bio Technologies:

Country of listing: India
Exchange: BSE
Ticker Symbol: 538858
What kind of share is Camson Bio Technologies?

Based on an overall assessment of its quality, value and momentum, Camson Bio Technologies is currently classified as a Value Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Camson Bio Technologies share price forecast 2020?

We were not able to load any forecast data for Camson Bio Technologies.

How can I tell whether the Camson Bio Technologies share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Camson Bio Technologies. Over the past six months, the relative strength of its shares against the market has been -26.66%. At the current price of ₹3.31, shares in Camson Bio Technologies are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Camson Bio Technologies PE Ratio?

We were not able to find PE ratio data for Camson Bio Technologies.

Who are the key directors of Camson Bio Technologies?

Camson Bio Technologies's management team is headed by:

Dhirendra Kumar - MDR
Teck Seong Yong - DRC
Manoj Srivastava - IND
Goonj Rastogi - CCO
Who are the major shareholders of Camson Bio Technologies?

Here are the top five shareholders of Camson Bio Technologies based on the size of their shareholding:

CLSA Capital Partners Private Equity
Percentage owned: 19.57% (5.87m shares)
Shashtika Health Resort & SPA Pvt. Ltd. Corporation
Percentage owned: 9.3% (2.79m shares)
Kumar (Dhirendra) Individual Investor
Percentage owned: 6.48% (1.94m shares)
Silver Cross Marketing Pvt. Ltd. Corporation
Percentage owned: 3.25% (975k shares)
Singh (Karan) Individual Investor
Percentage owned: 2.83% (850k shares)
Similar to 538858
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.